期刊文献+

培美曲塞二钠联合顺铂治疗晚期腺型非小细胞肺癌的疗效观察 被引量:1

下载PDF
导出
摘要 目的探讨培美曲塞二钠联合顺铂治疗晚期腺型非小细胞肺癌的临床疗效。方法 48例腺型非小细胞肺癌患者,口服叶酸0.4 mg/d,3次/d,连续口服7 d,然后开始给予赛珍500 mg/m2加入100 ml0.9%氯化钠注射液,快速静脉滴注10 min,30 min后给予顺铂75 mg/m2静脉滴注2 h,同时给予水化、利尿,同时肌内注射维生素B121000μg,3周为1个周期。观察其治疗效果。结果本组48例完全缓解9例,部分缓解20例,稳定15例,进展4例,总有效率为60.42%,临床受益率为91.67%。结论培美曲塞二钠联合顺铂治疗晚期腺型非小细胞肺癌疗效显著,不良反应少,值得临床推广。
作者 叶建增
出处 《中国实用医药》 2015年第21期164-165,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献18

  • 1李树婷,马飞,孙燕.抗肿瘤代谢新药——培美曲塞[J].癌症进展,2005,3(5):471-476. 被引量:73
  • 2Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly[ J]. Eur J Cancer, 1997,33 (14) :2313-2314.
  • 3Han K, Cao W, Che J, et al. First line chemotherapy with weekly docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study[J]. J Thorac Oncol, 2009, 4(4) :512-517.
  • 4Tibaldi C, Vasile E, Antonuzzo A, et al. First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients : a multicenter phase II study [ J ]. Br J Cancer, 2008,98 ( 3 ) :558-563.
  • 5Giorgio CG, Pappalardo A, Russo A, et al. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) [ J ]. Lung Cancer, 2006, 51 ( 3 ) :357-362.
  • 6Pujol JL, Paul S, Chouaki N, et al. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) : a risk-benefit analysis[J]. J Thorac Oncol, 2007, 2(5) :397-401.
  • 7Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J]. J Clin Oncol, 2004, 22(9) :1589-1597,.
  • 8Kulkarni PM, Chen R, Anand T, et al. Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis [ J ]. Crit Rev Oncol Hematol, 2008, 67 (1): 64-70.
  • 9Weiss G J, Langer C, Rosell R, et al. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase Ⅲtrial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer [ J]. J Clin Oncol, 2006, 24 (27) :4405-4411.
  • 10Chattopadhyay S,Moran RG,Goldman ID,et al.Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications[J].Mol Cancer Ther,2007,6(2):404-417.

共引文献96

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部